Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy

Sorcha Forde, Jamie D. Matthews, Leila Jahangiri, Liam C. Lee, Nina Prokoph, Tim I.M. Malcolm, Olivier T. Giger, Natalie Bell, Helen Blair, Aengus O'Marcaigh, Owen Smith, Lukas Kenner, Simon Bomken, Gladstone A.A. Burke, Suzanne D. Turner*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    5 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)354-365
    Number of pages12
    JournalBritish Journal of Haematology
    Volume192
    Issue number2
    DOIs
    Publication statusPublished (VoR) - Jan 2021

    Funding

    We are grateful to Dave, Nic, Brenda and Matt for their support, courage and determination to put an end to childhood cancer in memory of Alex. SF, JDM, GAAB and SDT are supported with funding from the Alex Hulme Foundation. We thank the Cambridge NIHR BRC Cell Phenotyping Hub, Addenbrooke’s Hospital, Cambridge; Central Biomedical Services (CBS), Addenbrooke’s Hospital, Cambridge; Haematopathology and Oncology Diagnostic Service (HODS) Lab, Addenbrooke’s Hospital, Cambridge; and the Histology Lab, Department of Pathology, University of Cambridge. We are also extremely grateful to all the children and their parents who donated their tumour tissues for this study.

    Keywords

    • B-cell lymphoma
    • Burkitt lymphoma
    • murine cancer models
    • patient derived xenograft
    • relapse

    Fingerprint

    Dive into the research topics of 'Paediatric Burkitt lymphoma patient-derived xenografts capture disease characteristics over time and are a model for therapy'. Together they form a unique fingerprint.

    Cite this